Cargando…
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
BACKGROUND: Pharmacological treatment for bronchiolitis is primarily supportive because bronchodilators, steroids, and antibiotics, show little benefit. Clinical studies have suggested that nebulized 3% hypertonic solution is useful for infants with bronchiolitis. This study aims to evaluate the cos...
Autores principales: | Buendía, Jefferson Antonio, Acuña-Cordero, Ranniery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607832/ https://www.ncbi.nlm.nih.gov/pubmed/33138807 http://dx.doi.org/10.1186/s12913-020-05814-1 |
Ejemplares similares
-
The cost-utility of early use of high-flow nasal cannula in bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021) -
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021) -
Hypertonic saline (HS) for acute bronchiolitis: Systematic review and meta-analysis
por: Maguire, Chin, et al.
Publicado: (2015) -
Therapeutic effects of Ventolin versus hypertonic saline 3% for acute bronchiolitis in children
por: Zamani, Mohammad-Ali, et al.
Publicado: (2015) -
Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta‐analysis
por: Pereira, Renan A., et al.
Publicado: (2022)